S&P 500 Futures
(0.70%) 5 365.50 points
Dow Jones Futures
(0.18%) 39 855 points
Nasdaq Futures
(1.19%) 19 010 points
Oil
(0.97%) $78.32
Gas
(0.67%) $2.86
Gold
(-1.19%) $2 364.50
Silver
(-2.32%) $30.77
Platinum
(-0.28%) $1 046.80
USD/EUR
(-0.27%) $0.921
USD/NOK
(-0.87%) $10.60
USD/GBP
(-0.13%) $0.785
USD/RUB
(0.31%) $90.48

Realtime updates for Cyclo Therapeutics, Inc. [CYTH]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated22 May 2024 @ 16:00

-5.15% $ 1.290

Live Chart Being Loaded With Signals

Commentary (22 May 2024 @ 16:00):
Profile picture for Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease...

Stats
Today's Volume 23 780.00
Average Volume 92 269.00
Market Cap 36.91M
EPS $0 ( 2024-05-20 )
Next earnings date ( $-0.160 ) 2024-08-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.050
ATR14 $0.00600 (0.47%)
Insider Trading
Date Person Action Amount type
2024-02-13 Sieger Markus Buy 14 004 Common Stock
2024-02-13 Ostronic Francis Patrick Buy 8 703 Common Stock
2024-02-13 Toig Randall M. Buy 7 516 Common Stock
2024-02-13 Strattan Ce Rick Buy 6 963 Common Stock
2024-02-13 Wong Vivien Buy 6 330 Common Stock
INSIDER POWER
50.79
Last 99 transactions
Buy: 16 269 213 | Sell: 5 479 045

Cyclo Therapeutics, Inc. Correlation

10 Most Positive Correlations
TACT0.862
PANL0.861
TNGX0.845
PVBC0.841
HNVR0.841
DRIO0.837
FRHC0.835
BSBK0.831
NEPH0.83
RGC0.828
10 Most Negative Correlations
FTXN-0.871
GLDI-0.869
DXPE-0.86
ASTC-0.85
SANG-0.85
CDXC-0.848
IGLD-0.842
OCGN-0.838
RGLS-0.837
SLVO-0.837

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cyclo Therapeutics, Inc. Financials

Annual 2023
Revenue: $1.08M
Gross Profit: $-2.41M (-223.91 %)
EPS: $-1.230
FY 2023
Revenue: $1.08M
Gross Profit: $-2.41M (-223.91 %)
EPS: $-1.230
FY 2022
Revenue: $1.38M
Gross Profit: $1.24M (89.90 %)
EPS: $-1.810
FY 2021
Revenue: $1.59M
Gross Profit: $1.43M (90.16 %)
EPS: $-2.24

Financial Reports:

No articles found.

Cyclo Therapeutics, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators